However, there is clearly a need to identify additional biomarkers for breast cancer as all breast cancers do not express ER and/or HER2 and additionally, there is no perfect correlation between these biomarkers and the response to targeted treatment. The gene discussed is ERBB2; the disease is breast cancer.